Doctors complain of iPledge problems

Sep 06, 2006

Dermatologists have complained that the U.S. Food and Drug Administration's iPledge program is delaying treatment for patients who require the drug Accutane.

The program, which was adapted six months ago to prevent the drug from causing birth defects in pregnant women, requires registration of wholesalers, pharmacists, doctors and patients involved with it. However, many doctors complain the program's customer service is difficult to deal with and often full of misinformation, The Washington Post reported Wednesday.

The American Academy of Dermatology released a survey last week reporting 90 percent of 378 physicians polled over the phone said they had experienced problems with the program. More than 50 percent of the polled doctors said treatment had been delayed for some patients because problems with the program prevented them from obtaining the prescription within seven days, and 39 percent said patients had complained of technical problems using the program's Web site.

Many doctors have called for the program to be revised.

"Every single one of my patients has had a problem" said dermatologist Sandra Read of the AAD board. "I don't care how smart you are -- this is an extremely confusing program with a very steep learning curve."

Copyright 2006 by United Press International

Explore further: Canada pledges $440 million to vaccinate poor children

add to favorites email to friend print save as pdf

Related Stories

Better diagnostic imaging for traumatic brain injuries

Oct 27, 2014

Image-calibration technology designed and developed by scientists at the National Institute of Standards and Technology (NIST) in collaboration with the National Cancer Institute and the Radiological Society ...

Recommended for you

Syria hit by flesh-eating maggot disease

7 hours ago

Three cases of myiasis have been reported near Damascus, marking the first appearance of the flesh-eating maggot disease in Syria, UN health experts said Friday.

Brazil's Amazon region houses latex 'love factory'

8 hours ago

Deep in Amazonia, Raimundo Pereira expertly cuts a gash in a rubber tree to collect white sap destined for the nearby factory at Xapuri, the world's only producer of contraceptives made from tropical forest latex.

Ebola scare boosts business for US company

8 hours ago

The Ebola scare has subsided in the United States, at least temporarily, but an Alabama manufacturer is still trying to catch up with a glut of orders for gear to protect against the disease.

Sperm can carry Ebola for 82 days: WHO

8 hours ago

Sperm can carry the Ebola virus for at least 82 days, the World Health Organization said Friday, urging men recovering from the disease to use condoms for three months after the onset of symptoms.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.